Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A prodrug system for hydroxylamines based on esterase catalysis.

Ana Conejo-Garcia1, Christopher J Schofield

  • 1Department of Chemistry and Oxford Centre for Molecular Sciences, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.

Bioorganic & Medicinal Chemistry Letters
|July 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benzoxazine-Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action.

Pharmaceutics·2025
Same author

CD44-targeted N-benzyltetrahydroisoquinoline derivatives as anticancer agents with high tumor-to-normal cell selectivity.

European journal of medicinal chemistry·2025
Same author

New N-Alkylketonetetrahydroisoquinoline derivatives exhibits antitumor effect by HA-CD44 interaction inhibition in MDA-MB-231 breast cancer.

Bioorganic chemistry·2025
Same author

New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death.

Bioorganic & medicinal chemistry·2024
Same author

Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats.

Drug design, development and therapy·2024
Same author

Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme.

Purinergic signalling·2023

Hydroxy hydroxamates serve as prodrugs for hydroxylamine. Gamma-hydroxy hydroxamates release hydroxylamine through lactonisation, while all hydroxamates can be hydrolyzed by esterases.

Area of Science:

  • Organic Chemistry
  • Medicinal Chemistry
  • Drug Delivery

Background:

  • Hydroxylamine is a reactive species with therapeutic potential.
  • Developing stable prodrugs for hydroxylamine is crucial for its effective delivery.
  • Hydroxy hydroxamates are explored as potential prodrug candidates.

Purpose of the Study:

  • To synthesize and characterize hydroxy hydroxamates.
  • To investigate the reactivity and stability of these compounds.
  • To evaluate their potential as prodrugs for hydroxylamine release.

Main Methods:

  • Synthesis of gamma-hydroxy hydroxamates.
  • Lactonisation studies to assess hydroxylamine release.
  • Esterase-catalyzed hydrolysis assays.

Related Experiment Videos

Main Results:

  • Gamma-hydroxy hydroxamates were successfully synthesized.
  • Lactonisation was identified as a mechanism for hydroxylamine release from gamma-hydroxy hydroxamates.
  • Hydroxamates demonstrated susceptibility to esterase-catalyzed hydrolysis.

Conclusions:

  • Hydroxy hydroxamates are viable prodrug models for hydroxylamine.
  • The release mechanism can be controlled through structural modification (e.g., gamma-hydroxy substitution).
  • Esterase-mediated hydrolysis offers another pathway for prodrug activation.